Northside Hospital, Inc.

This study is testing if giving an immunosuppressant drug called tacrolimus earlier in the transplant process can safely reduce a dangerous immune reaction called Cytokine Release Syndrome (CRS). It involves 20 adults with blood cancers who are receiving a stem cell transplant fr…

This study is testing whether a powerful cancer treatment called CAR-T therapy can be safely given to people with moderate to severe kidney problems. Researchers are adjusting the dose of the chemotherapy drugs given right before the CAR-T cells to see if it reduces serious side …

This study tests a bone marrow transplant method for people with severe aplastic anemia who don't have perfectly matched family donors. Researchers are using partially matched family donors along with specific medications after transplant to help the body accept the new cells. Th…

This trial is testing a modified bone marrow transplant procedure for people with blood cancers. It's designed for patients who need a transplant but only have a partially matched family donor. The study will see if using a lower-intensity preparation treatment before the transpl…

This study is testing if a drug called sargramostim can help patients recover their immune cells faster and with fewer serious infections after a half-matched stem cell transplant for blood cancers. It will involve about 38 patients who have a partially matched family donor. Rese…

This study is testing a two-drug combination (belumosudil and rituximab) as the first treatment for people who develop extensive chronic graft-versus-host disease after a bone marrow transplant. The trial will enroll 25 patients who haven't received previous treatment for this co…

This study is testing if giving a protective chemotherapy directly into the spinal fluid before and during a powerful leukemia drug (blinatumomab) can prevent brain-related side effects. The goal is to keep the drug's cancer-fighting power while shielding the nervous system. It i…